Prospective human factor validation study of epinephrine prefilled syringe (Symjepi) for the treatment of acute anaphylaxis.
Phase of Trial: Phase III
Latest Information Update: 13 Mar 2018
Price : $35 *
At a glance
- Drugs Epinephrine (Primary)
- Indications Anaphylaxis
- Focus Registrational; Therapeutic Use
- 13 Mar 2018 New trial record
- 06 Mar 2018 According to the Adamis Pharmaceuticals Corporation, company provided an update on data presented at the American Academy of Allergy, Asthma, and Immunology (AAAAI) joint congress with the World Allergy Organization.
- 06 Mar 2018 Results presented in the Adamis Pharmaceuticals Corporation media release.